610

· Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 610, covering 2022-09-06 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma [Phase 2]